Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by DJDawg on Nov 03, 2023 11:14am

Of interest

Someone I know who was part of the summer offering (part 1) said that the shares from that offering became tradeable for the first time this morning.

As such, there is a chance (hard to say) that some of the new volume is from those shares being cycled into the market so buyers from that offering can swing into the LIFE offering.
Comment by riverrrow on Nov 03, 2023 11:46am
Makes sense although that offering turned out to be pretty small.  The offering also was at 25 cents so in a sense they're taking a loss.  It all depends on how much investors value the attached warrants in this offering and wether or not they are tradeable. 
Comment by DJDawg on Nov 03, 2023 11:57am
Yes. all very strange. Whoever sold their shares for 0.16 today should try to buy them back at the current 0.19 right now.
Comment by Tapps21 on Nov 03, 2023 1:08pm
RDW is in his office right now salivating and overjoyed that this PP has been over prescribed or he's hiding under his desk asking himself how such a powerful ACT is falling through the cracks
Comment by O12009 on Nov 03, 2023 1:15pm
A lot of the shares where sold between the same company which is the same ones that have been driving the sp down all along. Nothing to see here folks, it has been going on for years. They have been successful in getting the sp down below the pp to discourage investors. And during all this the securities commission looks the other way.
Comment by Dumbeldorfwhite on Nov 03, 2023 8:09pm
Yup same old conspiracy theorists; maybe the sp has something to do with uhh poor company performance. Approval for bladder cancer simply isn't what it used to be now that there are more and more options each passing month
Comment by Donein25 on Nov 03, 2023 9:01pm
Tell us something then smart guy; at $40m market cap, is all our potential upside already priced in? A best in class with stellar safety profile is fairly priced at this level? If so, then your job is done. Good bye clown. 
Comment by Dumbeldorfwhite on Nov 04, 2023 10:47am
Yup 40 million is generous for a company that is burning money constantly and has yet to bring 1 drug to market and has 3 more years likely until completion of the trial and has a laser division that I'm not too sure what they do actually
Comment by Oilminerdeluxe on Nov 04, 2023 10:51am
Stop being a jerk. I am sure it amuses you, but have some dignity, please. How old are you? 12.?
Comment by Feedman2980 on Nov 04, 2023 11:42am
you can walk away anytime. If you don't like what is going on you can take what you have in it (if any) and invest elsewhere i am not sure why people who feel so strongly TLT is a dud take the time to follow and comment Those who believe in the science and potential choose to stay that is our choice. You have one too
Comment by N0taP00p on Nov 04, 2023 12:52pm
@feedman.  Because it brings balance. Because it's a message board.  There are  perennial hopefuls here who find warmth, goodness and the holy spirit in every delay announced by their God, the CEO .  You can do the same thing you're telling Dumb. Just don't read what you don't like or don't want to accept. No? 
Comment by socksnblonds642 on Nov 05, 2023 8:30am
Balance to the force! Sith lord much?
Comment by N0taP00p on Nov 05, 2023 9:50am
Yes, socksnblonds.  This board is overloaded with wannabe Jedis. A few Sith can't hurt to keep the  balance.   There are a handful of Jedis that i listen to.  They show up now and then. They understand the Force of investing. 
Comment by Dumbeldorfwhite on Nov 04, 2023 2:23pm
kinda like what Vera and Shawn did?
Comment by Dumbeldorfwhite on Nov 04, 2023 2:25pm
Kinda hard to walk away without anyone there to buy your shares without taking an absolute monster loss
Comment by Legit62 on Nov 04, 2023 7:31pm
They are paid bashers with no stake in TLT, or they have no life and it gives them satisfaction to get on every board they can. regardless who gives one sh-t what they say, if you believe this science will pay off, then good, or we wouldnt be invested here
Comment by Donein25 on Nov 04, 2023 12:09pm
You're living up to your name now Dumb. 
Comment by Bigkahuna57 on Nov 04, 2023 12:19pm
This post has been removed in accordance with Community Policy
Comment by Bigkahuna57 on Nov 05, 2023 9:34am
Re Dumb, The only points one may conclude about your posts are you don't understand how a drug is brought to market, or the clinical trial process, and you don't understand the data that's been presented and peer reviewed?  For the past year the data has continued to show better results for the tested groups.  Clearly you don't know how to run a company and control it if ...more  
Comment by Alamir1111 on Nov 05, 2023 10:29am
Yes it's clearly shown how to run a public company. Osc kicks his a out for 2 years.Money issues .Dilution every quarter .Missed deadlines.Boatloads of publications worth .18 pennies..But we all like the technology 
Comment by Oilminerdeluxe on Nov 05, 2023 12:55pm
18 cents. I guess there is room for a few more in the coffers tomorrow
Comment by Dumbeldorfwhite on Nov 05, 2023 4:45pm
You can bash people all you want but you can't argue with a stock price near all time lows
Comment by StevenBirch on Nov 03, 2023 2:30pm
TD sold it all the way down and since have probably bought it all back, with Scotia being the big seller. Same old same old.
Comment by wildbird1 on Nov 06, 2023 6:15am
I agree StevenBirch. On October 23,2023 before the financing the SP was at 0.26$, today it is at 0.18$...a drop of 30%. Yes a drop of 30% is big, but at the same time only 1-2% of the total shares out were traded. Meaning... Approximately 98-99% of TLT total shares out, are still in the hands of strong believers. -Because the phase11 trial results are getting better and better.... -Because TLT ...more  
Comment by joeblows on Nov 04, 2023 4:19am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250